OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting IRG1 reverses the immunosuppressive function of tumor-associated macrophages and enhances cancer immunotherapy
Yujia Chen, Guan-Nan Li, Xian-Jing Li, et al.
Science Advances (2023) Vol. 9, Iss. 17
Open Access | Times Cited: 82

Showing 1-25 of 82 citing articles:

Embracing cancer complexity: Hallmarks of systemic disease
Charles Swanton, Elsa Bernard, Chris Abbosh, et al.
Cell (2024) Vol. 187, Iss. 7, pp. 1589-1616
Open Access | Times Cited: 146

ABCG2 is an itaconate exporter that limits antibacterial innate immunity by alleviating TFEB-dependent lysosomal biogenesis
Chao Chen, Zhenxing Zhang, Caiyun Liu, et al.
Cell Metabolism (2024) Vol. 36, Iss. 3, pp. 498-510.e11
Closed Access | Times Cited: 30

Itaconate impairs immune control of Plasmodium by enhancing mtDNA-mediated PD-L1 expression in monocyte-derived dendritic cells
Theresa Ramalho, Patrícia A. Assis, Ogooluwa Ojelabi, et al.
Cell Metabolism (2024) Vol. 36, Iss. 3, pp. 484-497.e6
Open Access | Times Cited: 25

Hematopoietic aging promotes cancer by fueling IL-1⍺–driven emergency myelopoiesis
Matthew D. Park, Jessica Le Bérichel, Pauline Hamon, et al.
Science (2024) Vol. 386, Iss. 6720
Open Access | Times Cited: 25

Biointerface‐Engineered Hybrid Nanovesicles for Targeted Reprogramming of Tumor Microenvironment
Xueyan Zhen, Yongjiang Li, Wanqing Yuan, et al.
Advanced Materials (2024) Vol. 36, Iss. 41
Closed Access | Times Cited: 20

A new era of cancer immunotherapy: combining revolutionary technologies for enhanced CAR-M therapy
Na Li, Shinan Geng, Zhenzhen Dong, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 19

Activating innate immune responses repolarizes hPSC-derived CAR macrophages to improve anti-tumor activity
Jun Shen, Shuzhen Lyu, Yingxi Xu, et al.
Cell stem cell (2024) Vol. 31, Iss. 7, pp. 1003-1019.e9
Closed Access | Times Cited: 17

Itaconate in host inflammation and defense
Dan Ye, Pu Wang, Leilei Chen, et al.
Trends in Endocrinology and Metabolism (2024) Vol. 35, Iss. 7, pp. 586-606
Closed Access | Times Cited: 16

Itaconate transporter SLC13A3 confers immunotherapy resistance via alkylation-mediated stabilization of PD-L1
Yizeng Fan, Weichao Dan, Yuzhao Wang, et al.
Cell Metabolism (2025)
Open Access | Times Cited: 2

Itaconate suppresses atherosclerosis by activating a Nrf2-dependent antiinflammatory response in macrophages in mice
Jianrui Song, Yanling Zhang, Ryan A. Frieler, et al.
Journal of Clinical Investigation (2023) Vol. 134, Iss. 3
Open Access | Times Cited: 32

Enhancing cancer immunotherapy: Nanotechnology-mediated immunotherapy overcoming immunosuppression
Yunna Chen, Qianqian Zhou, Zongfang Jia, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 9, pp. 3834-3854
Open Access | Times Cited: 12

Control of immune cell signaling by the immuno-metabolite itaconate
Roland Lang, Md Nur A Alam Siddique
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 11

CSF1R inhibition reprograms tumor-associated macrophages to potentiate anti-PD-1 therapy efficacy against colorectal cancer
Qi Lv, Yishu Zhang, Wenxue Gao, et al.
Pharmacological Research (2024) Vol. 202, pp. 107126-107126
Open Access | Times Cited: 11

Itaconate uptake via SLC13A3 improves hepatic antibacterial innate immunity
Chao Chen, Caiyun Liu, Pengkai Sun, et al.
Developmental Cell (2024) Vol. 59, Iss. 21, pp. 2807-2817.e8
Closed Access | Times Cited: 9

Itaconate transporter SLC13A3 impairs tumor immunity via endowing ferroptosis resistance
Heng Lin, Kole Tison, Yuheng Du, et al.
Cancer Cell (2024) Vol. 42, Iss. 12, pp. 2032-2044.e6
Open Access | Times Cited: 8

In vivo itaconate tracing reveals degradation pathway and turnover kinetics
Hanna Friederike Willenbockel, Alexander T. Williams, Alfredo Lucas, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Closed Access | Times Cited: 1

Targeting macrophages in cancer immunotherapy: Frontiers and challenges
Yue Liu, Huabing Tan, Jingyuan Dai, et al.
Journal of Advanced Research (2025)
Open Access | Times Cited: 1

Complement C3 of tumor-derived extracellular vesicles promotes metastasis of RCC via recruitment of immunosuppressive myeloid cells
Yibi Zhang, Xiaodong Wang, Yinmin Gu, et al.
Proceedings of the National Academy of Sciences (2025) Vol. 122, Iss. 4
Open Access | Times Cited: 1

Linking macrophage metabolism to function in the tumor microenvironment
Robbie Jin, Luke Neufeld, Tracy L. McGaha
Nature Cancer (2025)
Closed Access | Times Cited: 1

MMP28 recruits M2-type tumor-associated macrophages through MAPK/JNK signaling pathway-dependent cytokine secretion to promote the malignant progression of pancreatic cancer
Shi Dong, Xin Li, Chen Zhou, et al.
Journal of Experimental & Clinical Cancer Research (2025) Vol. 44, Iss. 1
Open Access | Times Cited: 1

GDP-bound Rab37 modulates M2-like tumor-associated macrophage polarization by attenuating STAT1 translocation to downregulate the type I IFN pathway
Chen-Tai Hong, You-En Yang, Hsueh‐Fen Juan, et al.
British Journal of Cancer (2025)
Closed Access | Times Cited: 1

Immunometabolism of tumor-associated macrophages: a therapeutic perspective
A. F. Karimova, Adelya R. Khalitova, Роман В. Суезов, et al.
European Journal of Cancer (2025), pp. 115332-115332
Open Access | Times Cited: 1

Itaconate restrains acute proinflammatory activation of microglia MG after traumatic brain injury in mice
Ning Liu, Yinghua Jiang, Yuwen Xiu, et al.
Science Translational Medicine (2025) Vol. 17, Iss. 789
Closed Access | Times Cited: 1

IRG1 restrains M2 macrophage polarization and suppresses intrahepatic cholangiocarcinoma progression via the CCL18/STAT3 pathway
Menghua Zhou, Hongjun Yu, Miaoyu Bai, et al.
Cancer Science (2024) Vol. 115, Iss. 3, pp. 777-790
Open Access | Times Cited: 7

Page 1 - Next Page

Scroll to top